OX40 Monoclonal Antibody (7D6), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA516548-Each-of-1 | In Stock | ₹ 26,299.50 |
PIMA516548 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 26,299.50
GST (18%): ₹ 4,733.91
Total Price: ₹ 31,033.41
Antigen
OX40
Classification
Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 0.09% sodium azide
Gene Accession No.
P43489
Gene Symbols
Tnfrsf4
Immunogen
CHO-derived feline CD134-Fc fusion protein.
Quantity
100 μg
Primary or Secondary
Primary
Target Species
Feline, Human
Product Type
Antibody
Isotype
IgG1
Applications
Flow Cytometry, Western Blot
Clone
7D6
Conjugate
Unconjugated
Gene
Tnfrsf4
Gene Alias
ACT35; ACT35 antigen; ATC35 antigen; CD134; CD134 antigen; IMD16; Ly-70; lymphoid activation antigene ACT35; MRC OX40; Ox40; OX40 antigen; OX40 cell surface antigen; OX40 homologue; OX40L receptor; TAX transcriptionally-activated glycoprotein 1 receptor; tax-transcriptionally activated glycoprotein 1; tax-transcriptionally activated glycoprotein 1 receptor; TNF receptor superfamily member 4; Tnfrsf4; tumor necrosis factor (ligand) superfamily member 4; tumor necrosis factor receptor superfamily member 4; tumor necrosis factor receptor superfamily, member 4; tumor necrosis factor superfamily, member 4; Txgp1; Txgp1l
Host Species
Mouse
Purification Method
Protein A
Regulatory Status
RUO
Gene ID (Entrez)
493665, 7293
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Related Products
Description
- This antibody does not react with mouse
- For FACS analysis, use 10 μL of the suggested working dilution to label 1x10^6 cells in 100 μL
- In Western blot, this antibody detects a band at ∽43 kDa
- OX40 is a protein receptor found on the surface of T cells, a type of white blood cell that plays a crucial role in the immune system
- When activated, OX40 promotes the proliferation and survival of T cells, leading to a stronger immune response against cancer cells and infectious agents
- OX40 agonists, which are drugs that activate OX40, have shown promising results in preclinical and clinical studies as a potential immunotherapy for cancer
- They can enhance the efficacy of other cancer treatments such as chemotherapy and checkpoint inhibitors, and may also have applications in autoimmune diseases and allergies.